5 results on '"Italian Association of Psychogeriatrics."'
Search Results
2. Guidelines for the Treatment of Alzheimer??s Disease from the Italian Association of Psychogeriatrics
- Author
-
Caltagirone, C., Bianchetti, A., Di Luca, M., Mecocci, P., Padovani, A., Pirfo, E., Scapicchio, P., Senin, U, Trabucchi, M, Musicco, M, and for Italian Association of Psychogeriatrics
- Subjects
Gerontology ,medicine.medical_specialty ,Psychological intervention ,Scientific evidence ,Alzheimer Disease ,Memantine ,Galantamine ,Cholinesterase Inhibitors ,Psychotherapy ,Humans ,Clinical Trials as Topic ,Aged ,Depressive Disorder ,Italy ,Excitatory Amino Acid Antagonists ,Medicine ,Dementia ,Pharmacology (medical) ,Donepezil ,Geriatrics ,Rivastigmine ,business.industry ,medicine.disease ,Family medicine ,Settore MED/26 - Neurologia ,Geriatrics and Gerontology ,Alzheimer's disease ,business ,medicine.drug - Abstract
A committee of experts from the Italian Association of Psychogeriatrics compiled the following report, which was then approved by a Steering Committee (comprising 20 specialists in neurology, psychiatry or geriatrics) from the Association and by two Alzheimer associations representing patients and families: the Italian Association for Alzheimer's Disease and the Italian Federation for Alzheimer's Disease. The report is based on a comprehensive review of the scientific literature on the treatment of Alzheimer's disease, discusses methodological aspects of dementia management, and details the limitations of current therapies. These guidelines are, in general, consistent with the principles of evidence-based medicine; however, for some controversial or poorly investigated issues, the guidelines integrate scientific evidence with experience and opinions from experts working in the clinical setting. In particular, the clinical experience of experts has been used to define recommendations for starting and interrupting pharmacotherapy, and to critically review evidence about the efficacy of non-pharmacological interventions. The principal pharmacotherapeutic interventions covered in the guidelines are acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine, and tacrine) and memantine. The main non-pharmacological interventions reviewed are memory training, reality orientation therapy, and combined non-pharmacological interventions. Other issues covered are opportunities for Alzheimer's disease prevention, various modalities of care, and the treatment of comorbidities.
- Published
- 2005
3. Radiological assessment of dementia: the Italian inter-society consensus for a practical and clinically oriented guide to image acquisition, evaluation, and reporting.
- Author
-
Pizzini FB, Conti E, Bianchetti A, Splendiani A, Fusco D, Caranci F, Bozzao A, Landi F, Gandolfo N, Farina L, Miele V, Trabucchi M, Frisoni GB, and Bastianello S
- Subjects
- Biomarkers, Consensus, Humans, Magnetic Resonance Imaging methods, Dementia diagnostic imaging, Neuroimaging methods
- Abstract
Background: Radiological evaluation of dementia is expected to increase more and more in routine practice due to both the primary role of neuroimaging in the diagnostic pathway and the increasing incidence of the disease. Despite this, radiologists often do not follow a disease-oriented approach to image interpretation, for several reasons, leading to reports of limited value to clinicians. In our work, through an intersocietal consensus on the main mandatory knowledge about dementia, we proposed a disease-oriented protocol to optimize and standardize the acquisition/evaluation/interpretation and reporting of radiological images. Our main purpose is to provide a practical guideline for the radiologist to help increase the effectiveness of interdisciplinary dialogue and diagnostic accuracy in daily practice., Results: We defined key clinical and imaging features of the dementias (A), recommended MRI protocol (B), proposed a disease-oriented imaging evaluation and interpretation (C) and report (D) with a glimpse to future avenues (E). The proposed radiological practice is to systematically evaluate and score atrophy, white matter changes, microbleeds, small vessel disease, consider the use of quantitative measures using commercial software tools critically, and adopt a structured disease-oriented report. In the expanding field of cognitive disorders, the only effective assessment approach is the standardized disease-oriented one, which includes a multidisciplinary integration of the clinical picture, MRI, CSF and blood biomarkers and nuclear medicine., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
4. Medico-legal assessment of personal damage in older people: report from a multidisciplinary consensus conference.
- Author
-
Ingravallo F, Cerquetti I, Vignatelli L, Albertini S, Bolcato M, Camerlingo M, Corbi G, De Leo D, De Nicolò A, De Stefano F, Dell'Erba A, Di Giulio P, Domenici R, Fedeli P, Feola A, Ferrara N, Forti P, Frigiolini F, Gianniti P, Gili E, Iannone P, Lovato A, Lunardelli ML, Marengoni A, Marozzi F, Martelloni M, Mecocci P, Molinelli A, Polo L, Portas M, Rossi P, Scorretti C, Trabucchi M, Volpato S, Zoja R, and Castellani GL
- Subjects
- Aged, Aged, 80 and over, Functional Status, Geriatric Assessment, Health Status, Humans, Italy, Liability, Legal, Accidental Injuries, Aging, Forensic Medicine
- Abstract
Ageing of the global population represents a challenge for national healthcare systems and healthcare professionals, including medico-legal experts, who assess personal damage in an increasing number of older people. Personal damage evaluation in older people is complex, and the scarcity of evidence is hindering the development of formal guidelines on the subject. The main objectives of the first multidisciplinary Consensus Conference on Medico-Legal Assessment of Personal Damage in Older People were to increase knowledge on the subject and establish standard procedures in this field. The conference, organized according to the guidelines issued by the Italian National Institute of Health (ISS), was held in Bologna (Italy) on June 8, 2019 with the support of national scientific societies, professional organizations, and stakeholders. The Scientific Technical Committee prepared 16 questions on 4 thematic areas: (1) differences in injury outcomes in older people compared to younger people and their relevance in personal damage assessment; (2) pre-existing status reconstruction and evaluation; (3) medico-legal examination procedures; (4) multidimensional assessment and scales. The Scientific Secretariat reviewed relevant literature and documents, rated their quality, and summarized evidence. During conference plenary public sessions, 4 pairs of experts reported on each thematic area. After the last session, a multidisciplinary Jury Panel (15 members) drafted the consensus statements. The present report describes Conference methods and results, including a summary of evidence supporting each statement, and areas requiring further investigation. The methodological recommendations issued during the Conference may be useful in several contexts of damage assessment, or to other medico-legal evaluation fields.
- Published
- 2020
- Full Text
- View/download PDF
5. Timely Detection of Mild Cognitive Impairment in Italy: An Expert Opinion.
- Author
-
Bianchetti A, Ferrara N, Padovani A, Scarpini E, Trabucchi M, and Maggi S
- Subjects
- Biomarkers, Cognitive Dysfunction epidemiology, Disease Progression, Humans, Italy, Neuropsychological Tests, Prevalence, Cognitive Dysfunction diagnosis, Early Diagnosis
- Abstract
Mild cognitive impairment (MCI) generally evolves in a gradually progressive decline in memory and non-memory cognitive domains that may eventually decay to dementia. This process might be preventable by improving early detection of the MCI syndrome followed by proper and timely interventions. The aim of this work was providing helpful indications for a standardized early diagnosis of MCI, mainly focusing on the Italian elderly population. We reviewed here MCI epidemiology and classification, as well as the most recent advancements in early detection of the patient with MCI in the Italian scenario. Specialist centers in connection with general practitioners (GPs) have been established across the country and designated as Centers for Cognitive Disorders and Dementia (CDCD). CDCDs are dedicated to the diagnosis and management of patients for all forms of dementia across all the complex staging spectrum. New tools were made available by the advancements of imaging techniques and of the research on biomarkers, leading to novel approaches based on the combination of imaging and biomarker detection, to improve accuracy and effectiveness in the early diagnosis of MCI. Moreover, patient genotyping, alone or in combination with other techniques, was also revealed as a promising method in evaluating and preventing MCI progression. We recommend the introduction of all these novel tools in the diagnostic practice of the specialist centers and that further efforts and resources are spent into the research of the most effective techniques and biomarkers to be introduced as first-level tests into the practice of early diagnosis of MCI.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.